Nasdaq reports that Pfizer has completed its acquisition of Illinois-based medical device company Hospira. Based on recent device recalls, the Hospira acquisition may result in additional lawsuits for Pfizer, which is already defending a number of its own cases involving Lipitor and Zoloft.
The past six months have seen a slew of recalls and warning letters from the U.S. Food and Drug Administration (FDA) concerning Hospira ...
continue reading...